We are looking for children 2–17 years old to join a CD study to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or moderate to severe Crohn’s disease (including associated symptoms such as abdominal cramping, perianal fistula, rectal pain, weight loss and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
